Inhibrx Biosciences(Inbx) Financials: Fixed Asset Turnover Compared To Industry Average, Plus Other Key Ratios
Growth Trend (Last 5 Years)
Growth - fixed asset turnover
This chart shows the historical trend of fixed asset turnover for INBX compared to its industry average over the recent years.
Ratio Definition and Interpretation
Name: Fixed Asset Turnover
Definition: Fixed asset turnover shows how well the company’s long-term physical assets — factories, equipment, property — are being used to generate sales. A high ratio means the company’s facilities are productive and efficient. A low ratio might signal underused assets or over-investment in equipment that isn’t driving enough sales.
Interpretation:
• In '2022', INBX's fixed asset turnover was 0.18, illustrating how efficiently fixed assets are generating revenue. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2022' stood at 0.97.
• In '2023', INBX's fixed asset turnover was 0.22, illustrating how efficiently fixed assets are generating revenue. The increase since '2022' reflects strengthening financial performance. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2023' stood at 0.99. Industry average increased by 0.01 compared to previous year.
• In '2024', INBX's fixed asset turnover was 0.02, illustrating how efficiently fixed assets are generating revenue. The decline from '2023' may indicate some operational or financial challenges. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2024' stood at 1.05. Industry average increased by 0.07 compared to previous year.
Overall, INBX's fixed asset turnover has been volatile but showed a downward trend over the past 3 years.
Formula: Fixed Asset Turnover = Net Sales / Net Fixed Assets
Good Range: Ranges from 1 to 5 depending on asset intensity.